Table 2 Metabolic syndrome components and prevalence of metabolic syndrome and its risk factors by categories of dietary total antioxidant capacity: Tehran Lipid and Glucose Study¹
( n = 1938) | |||||
|---|---|---|---|---|---|
Q1 | Q2 | Q3 | Q4 | P2 | |
Total antioxidant capacity | |||||
Range | < 842 | 842-958 | 959-1080 | > 1080 | |
Median | 764 | 906 | 1014 | 1161 | |
Waist circumference (cm) | 90 ± 0.5 | 89.0 ± 0.5 | 89 ± 0.5 | 89 ± 0.5 | 0.44 |
Fasting blood glucose (mg/dl) | 93 ± 1.1 | 91 ± 1.1 | 91 ± 1.1 | 90 ± 1.1 | 0.46 |
Serum triglycerides (mg/dl) | 148 ± 3.7 | 142 ± 3.7 | 143 ± 3.7 | 137 ± 3.7 | 0.24 |
HDL-c (mg/dl) | 42.2 ± 0.4 | 41.8 ± 0.4 | 42.2 ± 0.4 | 42.5 ± 0.4 | 0.71 |
SBP (mmHg) | 112 ± 0.6 | 112 ± 0.6 | 111 ± 0.6 | 111 ± 0.6 | 0.75 |
DBP (mmHg) | 74 ± 0.4 | 74 ± 0.4 | 73 ± 0.4 | 73 ± 0.4 | 0.12 |
Abdominal obesity (%) | 44.2 | 43.7 | 46.5 | 38.8 | 0.10 |
Hypertriglyceridemia (%) | 34.5 | 31.8 | 30.7 | 31.1 | 0.57 |
Low HDL-c (%) | 49.2 | 50.9 | 51.2 | 47.6 | 0.65 |
Hyperglycemia (%) | 22.7 | 25.2 | 24.1 | 28.0 | 0.28 |
Hypertension (%) | 12.6 | 17.4 | 14.5 | 15.5 | 0.20 |
Metabolic syndrome (%) | 24.6 | 27.5 | 27.4 | 25.9 | 0.69 |